A company with a proven proprietary technology to generate unlimited supplies of multipotent stem cells for implantation to treat diseases currently only addressed by stem cell transplant


I was extremely sceptical. They did it in front of my eyes with my own blood. It’s stunning.

Professor Tim McCaffrey

We saw when the blood came out of the patient, and after it had been incubated with the antibody, there was a visible difference. After six days the guy had platelets and neutrophils he never had before.

Professor Richard Boyd
Live confocal movie demonstrating the conversion of healthy mature adult leukocytes to a stem cell stage following initiation of the retrodifferentiation process. The movie duration is 12 hours with a clip taken every 3 minutes. This movie demonstrates the loss of mature marker, CD19, on differentiated cells (stained green). Upon induction of the process of retrodifferentiation, the green stain disappears from the surface of the cell and the haematopoietic stem cell marker, CD34 (red stained), progressively increases on the surface of the cells; the hallmark of reverting back to a stem cell stage.
meet the team
Ghazi Dhoot
Chairman & Commercial Director
Prior to founding TriStem, Ghazi set up the Mergers & Acquisitions Division within the Corporate Finance Group, for The National Commercial...
Dr Ilham Saleh Abuljadayel
Chief Scientific Officer
Dr. Ilham Saleh Abuljadayel, is the sole inventor of the TriStem Technology, and co-founder.
Dr Keith Redpath
Chief Development Officer
Dr. Keith Redpath has been in the life sciences industry for over 30 years, having graduated from Heriot Watt University in Marine Biology, then...
Richard Williams
Chief Executive Officer
For the majority of his professional career Richard was with Arthur Andersen, where he qualified as Fellow of the Institute of Chartered...

Get In Touch

Contact Us